Wall Street bounces as trade temperature cools
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
UPDATE: Bristol-Myers Squibb (BMY), Presage Biosciences Announce Research Collaboration for Phase O Studies of Novel Cancer Agents Utilizing CIVO Technology
August 27, 2019 8:03 AM EDT(Updated - August 27, 2019 8:03 AM EDT)
Presage Biosciences, a cancer biotechnology company pioneering a new cancer drug development approach using its CIVO multiplexed intratumoral microdosing platform, today announced it has entered into a research collaboration with Bristol-Myers Squibb Company (NYSE: BMY) to evaluate early stage oncology targets in Phase 0 trials. Presage's CIVO... More
